ReviewJournal of diabetes and metabolic disorders2024
Evaluating the impact of efpeglenatide on cardiometabolic and safety outcomes in individuals with diabetes: a systematic review and meta-analysis.
Shurjeel Uddin Qazi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.